Literature DB >> 11290664

Do drug company promotions influence physician behavior?

B Goodman1.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2001        PMID: 11290664      PMCID: PMC1071337          DOI: 10.1136/ewjm.174.4.232

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  9 in total

1.  A piece of my mind: financial indigestion.

Authors:  J P Kassirer
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

2.  The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

Authors:  J P Orlowski; L Wateska
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

3.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.

Authors:  M M Chren; C S Landefeld
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

4.  The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

Authors: 
Journal:  Arch Intern Med       Date:  1993-01-25

5.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

6.  Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.

Authors:  M Pahor; B M Psaty; M H Alderman; W B Applegate; J D Williamson; C Cavazzini; C D Furberg
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

7.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

8.  Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  D Siegel; J Lopez
Journal:  JAMA       Date:  1997-12-03       Impact factor: 56.272

9.  A physician survey of the effect of drug sample availability on physicians' behavior.

Authors:  L D Chew; T S O'Young; T K Hazlet; K A Bradley; C Maynard; D S Lessler
Journal:  J Gen Intern Med       Date:  2000-07       Impact factor: 5.128

  9 in total
  7 in total

1.  Selling drugs to the public--should the UK follow the example of the US?

Authors:  John Frey
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

2.  Selling drugs to doctors--it's marketing, not education.

Authors:  Richelle Cooper; Jerome Hoffman
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

3.  Sources of information for new drugs among physicians in Thailand.

Authors:  Maneerat R Layton; Wanapa Sritanyarat; Supatra Chadbunchachai; Albert I Wertheimer
Journal:  Pharm World Sci       Date:  2007-08-21

4.  Spectrum of antihypertensive therapy in South Asians at a tertiary care hospital in Pakistan.

Authors:  Aysha Almas; Salik Ur Rehman Iqbal; Anabia Ehtamam; Aamir Hameed Khan
Journal:  BMC Res Notes       Date:  2011-09-01

5.  International variation in prescribing antihypertensive drugs: its extent and possible explanations.

Authors:  Atle Fretheim; Andrew D Oxman
Journal:  BMC Health Serv Res       Date:  2005-03-11       Impact factor: 2.655

6.  Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribing.

Authors:  Atle Fretheim
Journal:  BMC Fam Pract       Date:  2003-12-23       Impact factor: 2.497

7.  Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan.

Authors:  Pang-Hsiang Liu; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2008-06-18       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.